Source: Annual Congress 2011 - COPD mechanisms
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Cabrera Lopez, J. Zagaceta, C. Cote, M. Divo, J. P. De Torres, J. M. Marín, C. Casanova, V. Pinto-Plata, J. Zulueta, B. Celli, S. Carrizo (Las Palmas de G.C., Pamplona, Zaragoza, Santa Cruz de Tenerife, Spain; Tampa, Boston, United States Of America). The impact of comorbidities related to BMI in COPD patients. Eur Respir J 2011; 38: Suppl. 55, 3587

Member's Comments

No comment yet.

Related content which might interest you: Body composition in COPD patients with self-reported cardiovascular comorbidity Source: Eur Respir J 2007; 30: Suppl. 51, 452s Year: 2007 Association between comorbidities, disease severity and body mass index in COPD patients Source: Annual Congress 2011 - COPD diagnosis Year: 2011 The influence of smoking on hydrolipoperoxidation in COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 306s Year: 2003 COPD and comorbidities Source: Annual Congress 2009 - COPD comorbidities: translational approaches Year: 2009 Comparison of BMI and central obesity between asthma and COPD patients Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008 Prevalence of comorbidities in patients with COPD in south-Spain Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Prevalence of comorbidity in patients with COPD and its effect on mortality Source: Annual Congress 2003 - Staging and outcome in COPD Year: 2003 Higher BODE Index in COPD patients correlated with higher number of comorbidities Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Obesity, smoking and gender type as cardiovascular risk factors among COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 453s Year: 2007 ß2-adrenoceptor modulation in COPD and its potential impact on cardiovascular comorbidities Source: Eur Respir Monogr 2020; 88: 229-237 Year: 2020 Comorbidities in COPD patients are not associated to higher disease severity Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation Year: 2011 Pharmacological treatment of self-reported cardiovascular comorbidity in COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 453s Year: 2007 BMI is reduced in COPD. Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020 Disease-specific medication, patient-reported diagnoses and their relation to COPD severity for common comorbidities in COPD Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017 The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Role of comorbidities in stable COPD patients mortality Source: International Congress 2016 – Monitoring comorbidities Year: 2016 The relationship of comorbidities with clinical and phsyiological parameters in COPD Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Effect of weight loss on COPD-associated comorbidities in obese COPD Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases Year: 2021 COPD and BMI at primary level Source: International Congress 2015 – Different data in COPD Year: 2015